Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor
US10266899B2 · kind B2 · utility
0Cited by
9References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 20, 2015 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Feb 20, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides novel mitochondrial fusion transcripts and the parent mutated mtDNA molecules that are useful for predicting, diagnosing and/or monitoring cancer. Hybridization probes complementary thereto for use in the methods of the invention are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.